In: Press Release

HORSHAM, PA. – Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain management services for pharmaceutical, biotechnology, contract research and medical research organizations, announced today the appointment of Nitin Jain to a new position as Vice President of the Asia-Pacific (APAC) region.
Nitin will focus on driving operational excellence to support our client’s clinical supply chain needs and oversee the complete end-to-end supply chain management operations of Ancillare’s Singapore Master Depot. Nitin brings to Ancillare over 18 years of business development, general management, strategic alliances, supply chain management and operations experience in pharmaceutical, biotechnology and contract research organizations around the world. Nitin has held senior positions at INC Research, Covance, Theorem Clinical Research and Worldwide Clinical Trials.
“We see significant growth potential in the APAC region. Nitin’s extensive experience and strong drive makes him a great fit to lead our operations and growth in the APAC region,” said Joanne Santomauro, Chief Executive Officer at Ancillare. “By expanding our operations in Asia-Pacific this strengthens our ability to provide our clients with a single source for all their clinical trial supply chain needs.”

Singapore along with our strategic depots in China and Korea will provide Ancillare with the gateway to the entire APAC region by incorporating standard processes and procedures under one quality driven operation. The Singapore Operation will augment Ancillare’s strategic and master depot network so that our sponsors’ clinical operations leaders will have one point of expert contact and one clinical supply chain to manage all global trials needs from pre-protocol launch and first patient/first visit through last patient/last visit, site closeout and reclamation.

About Ancillare, LP
Ancillare, LP has extensive experience delivering cost savings and efficiencies to supply chains, with a complete turn-key approach for managing the pharmaceutical, biotechnology, contract research and medical research organizations’ clinical trial supply chains with a singular focus. Our turn-key global model (A-TKOTM) centralizes supply operations which accelerates the processes, lowers costs and mitigates risk by making clinical supply chains more efficient, cost-effective and global.

Our capabilities include pre-protocol analysis and planning, contribution to overall program feasibility assessments and timeline development, product sourcing and procurement, forecasting and budgeting, large and small equipment and consumables management, patient retention and recruitment materials, customs clearance, import/export (including IOR/EOR), storage, kitting, distribution and returns management/disposition (including destruction, refurbishment/recalibration and redeployment) on a global level.

Ancillare has master depots in United States, United Kingdom and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan and Ukraine. To learn more, visit ancillare.com or contact us via LinkedIn, Twitter and Facebook.

HORSHAM, PA.–Ancillare, LP’s Joanne Santomauro, Chief Executive Officer and Founder, is being recognized by Marcum LLP and Philadelphia SmartCEO as a finalist for their 2016 Marcum Innovator of the Year award.

The Marcum Innovator of the Year award honors business leaders who have developed products and services that improve the quality of life and business practice in Philadelphia. Finalists are pioneering new advancements in the biotechnology, healthcare, business services, manufacturing, real estate and technology industries. The winners will be announced on October 26, 2016 at the Sugarhouse Casino in Philadelphia, PA.

“I am honored to be recognized as a Marcum Innovator of the Year finalist. This recognition shows the dedication, support, commitment and excellence of the entire organization.” said Joanne Santomauro.

With Joanne’s forward thinking, she was able to create the ancillary supply chain management industry. Prior to the company’s launch in 2006, pharmaceutical, biotechnology and medical research organizations had little transparency and a lack of understanding of the associated costs, processes, regulatory and compliance requirements of the clinical supply chain. Over the last decade Joanne took the company to explosive growth around the world through dedication, innovative solutions including the Ancillare Turn Key Operative Model (A-TKO) and cutting-edge processes.

About Ancillare, LP
Ancillare, LP has extensive experience delivering cost savings and efficiencies to supply chains, with a complete turn-key approach for managing the pharmaceutical, biotechnology, contract research and medical research organizations’ clinical trial supply chains with a singular focus. Our turn-key global model (A-TKO) centralizes supply operations which accelerates the processes, lowers costs and mitigates risk by making clinical supply chains more efficient, cost-effective and global.
Our capabilities include pre-protocol analysis and planning, contribution to overall program feasibility assessments and timeline development, product sourcing and procurement, forecasting and budgeting, large and small equipment and consumables management, patient retention and recruitment materials, customs clearance, import/export (including IOR/EOR), storage, kitting, distribution and returns management/disposition (including destruction, refurbishment/recalibration and redeployment) on a global level.

Ancillare has managed the supply chain for top pharmaceutical and CRO organizations and has successfully transported goods to 100 countries. Ancillare has master depots in United States, United Kingdom and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan and Ukraine. To learn more, visit www.ancillare.com or contact us via LinkedIn, Twitter and Facebook.

HORSHAM, PA.– Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain management services for pharmaceutical, biotechnology, contract research and medical research organizations, will share expertise and best practices to the LogiPharma US 2016 conference in Princeton, New Jersey. Peter Knapp, Vice President of Logistics and Global Expansion at Ancillare, LP will chair and speak on relevant topics during the Innovating the Supply Chain track on September 21, 2016 beginning at 8:45AM.

With the growing complexities of global supply chains, increased regulations, new technologies, out of control costs, request for more transparency, the call for innovative solutions in the chain is a must. Peter Knapp will join other key thought leaders to address innovative solutions for transforming the supply chain, such as:

  • Juan Fernando Forero, Sr. Director Supply Chain Leader Global Innovation Pharma (GIP), Pfizer
  • Ronald Keegan, Associate Director Supply Chain at Ohm Labs, Sunpharma
  • Ed Ram, Director, Supplier Relations, Global Sourcing Department, Sagent
  • Paul Clayton, Former VP Supply Chain, Logistics and IT, Formerly GlaxoSmithKline
  • Plus Many More

LogiPharma is the largest global end-to-end supply chain forum for pharmaceutical supply chain leaders, their teams and service partners for exchanging knowledge and innovating ideas.

“Innovation is to amend our future” said Peter Knapp “Innovative supply chain management is the key enabler for globalization, lean management and cost control.”

“We are very excited for Peter to share important insights on innovating the supply chain in the 21st Century, said Joanne Santomauro, Chief Executive Officer and Founder at Ancillare, LP” “The ancillary supply chain management industry in 2006 was created by Ancillare, LP. Prior to the company launch, pharmaceutical, biotechnology and medical research organizations had little transparency to the overall supply chain and had a limited grasp of the associated costs, processes, and regulatory and compliance requirements of this diverse global supply chain.”

About Ancillare, LP

Ancillare, LP has extensive experience delivering cost savings and efficiencies to supply chains, with a complete turn-key approach for managing the pharmaceutical, biotechnology, contract research and medical research organizations’ clinical trial supply chains with a singular focus. Our turn-key global model (A-TKOTM) centralizes supply operations which accelerates the processes, lowers costs and mitigates risk by making clinical supply chains more efficient, cost-effective and global.

Our capabilities include pre-protocol analysis and planning, contribution to overall program feasibility assessments and timeline development, product sourcing and procurement, forecasting and budgeting, large and small equipment and consumables management, patient retention and recruitment materials, customs clearance, import/export (including IOR/EOR), storage, kitting, distribution and returns management/disposition (including destruction, refurbishment/recalibration and redeployment) on a global level.

Ancillare has managed the supply chain for top pharmaceutical and CRO organizations and has successfully transported goods to 100 countries. Ancillare has master depots in United States, United Kingdom and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan and Ukraine. To learn more, visit www.ancillare.com or contact us via LinkedIn, Twitter and Facebook.